Becton Dickinson Names Michael Feld President of Life-Sciences Segment
By Colin Kellaher
Becton Dickinson has hired Michael Feld as executive vice president and president of its life-sciences segment, effective Aug. 20.
Becton Dickinson on Monday said Feld joins the Franklin Lakes, N.J., medical-technology company from Danaher spinoff Veralto, where he was most recently president of the Hach water-quality products business.
Becton Dickinson's life-sciences segment accounted for $1.26 billion of the company's fiscal third-quarter revenue of nearly $5 billion.
The company earlier this year said David Hickey, who had been executive vice president and president of the life-sciences segment, was retiring.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
August 12, 2024 08:01 ET (12:01 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Q4 Stock Market Outlook: Where We See Opportunities for Investors
-
Markets Brief: Non-Farm Payrolls in the Spotlight Again
-
6 Top-Performing Large-Growth Funds
-
What’s the Difference Between the CPI and PCE Indexes?
-
10 Top-Performing Dividend Stocks of Q3 2024
-
33 Undervalued Stocks
-
Communication Services: Cable’s Broadband Dominance Isn’t as Strong as It Once Was
-
Technology: Strength Continues, With Software Presenting the Best Buying Opportunities
-
Best- and Worst-Performing Stocks of Q3 2024
-
Top Stocks to Own From the Best Fund Managers
-
2 Cheap Stocks Top Managers Have Been Buying
-
The 10 Best Companies to Invest in Now
United States